Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Aortic Interventions: Features

Video
EVAR Initial Case Example with Gore Active Control System from Erin Moore, MD
06/01/2022
Dr. Erin Moore discusses an EVAR initial case example using the Gore Active Control System.
Dr. Erin Moore discusses an EVAR initial case example using the Gore Active Control System.
Dr. Erin Moore discusses an EVAR...
06/01/2022
Vascular Disease Management
Review
Endovascular Aortic Arch Repair of Aortic Arch Lesions Using Hybrid Extra-Anatomic Reconstruction or Three-Vessel Branched Endografts
05/16/2022
Outcomes of hybrid repair.
Outcomes of hybrid repair.
Outcomes of hybrid repair.
05/16/2022
Vascular Disease Management
Case Report
Snaring a Popped-Out Transcatheter Aortic Valve Using Bioptome
05/16/2022
The authors present a case report where a deployed valve popped out due to underexpansion.
The authors present a case report where a deployed valve popped out due to underexpansion.
The authors present a case...
05/16/2022
Vascular Disease Management
Dr. Sukgu Han
VIdeo
Achieving Optimal TEVAR Positioning: Advantages and Learnings With the Gore TAG Conformable Thoracic Stent Graft with Active Control System
05/01/2022
Dr. Sukgu Han discusses achieving optimal TEVAR positioning in type B dissection.
Dr. Sukgu Han discusses achieving optimal TEVAR positioning in type B dissection.
Dr. Sukgu Han discusses...
05/01/2022
Vascular Disease Management
Original Research
Assessment of Monocyte Count to HDL Cholesterol Ratio in Patients With Ascending Aortic Dilatation
04/21/2022
The authors investigate the relationship between monocyte count to HDL-C ratio and AAD.
The authors investigate the relationship between monocyte count to HDL-C ratio and AAD.
The authors investigate the...
04/21/2022
Vascular Disease Management
Clinical Images
Negotiating Transcatheter Aortic Valve Replacement in Severe Peripheral Arterial Disease
03/14/2022
Performing TAVR on a 73-year-old man with a EuroSCORE II of 12%.
Performing TAVR on a 73-year-old man with a EuroSCORE II of 12%.
Performing TAVR on a 73-year-old...
03/14/2022
Vascular Disease Management
Dr. Joseph Lombardi
Video
Approaches to the False Lumen in Type B Dissection
02/23/2022
In this video from ISET 2022, Dr. Lombardi discusses his presentation on dealing with a false lumen in Type B aortic dissection.
In this video from ISET 2022, Dr. Lombardi discusses his presentation on dealing with a false lumen in Type B aortic dissection.
In this video from ISET 2022,...
02/23/2022
Vascular Disease Management
Dr. Barry Katzen
Video
TEVAR: Indications and Value of Multidisciplinary Teams
02/22/2022
In this video from ISET 2022, Dr. Katzen discusses the importance of multidisciplinary teamwork in thoracic endovascular aortic repair.
In this video from ISET 2022, Dr. Katzen discusses the importance of multidisciplinary teamwork in thoracic endovascular aortic repair.
In this video from ISET 2022,...
02/22/2022
Vascular Disease Management
Original Research
Blood Flow Analysis After a Renovisceral Debranching Procedure by Four-dimensional Flow Magnetic Resonance Imaging
01/19/2022
Analyzing blood flow.
Analyzing blood flow.
Analyzing blood flow.
01/19/2022
Vascular Disease Management
Large Vessel Closure Devices for Aortic Procedures
Presentation
Large Vessel Closure Devices for Aortic Procedures
01/17/2022
At ISET 2022, Zvonimir Krajcer, MD, reviews the approved and emerging dedicated large vessel closure devices available and how they are used. 
At ISET 2022, Zvonimir Krajcer, MD, reviews the approved and emerging dedicated large vessel closure devices available and how they are used. 
At ISET 2022, Zvonimir Krajcer,...
01/17/2022
Vascular Disease Management

Advertisement

Advertisement

Stay in the Know

Vascular Disease Management Newsletter

Advertisement

Advertisement

News

First Aid guidelines
AHA/American Red Cross: Updated First Aid Guidelines Enhance Care for Opioid Overdose, Bleeding, Other Emergencies
11/14/2024
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major...
11/14/2024
Cath Lab Digest
Late-Breaking Trials
Final Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/06/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a...
11/06/2024
Vascular Disease Management
Late-Breaking Trials
Third Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/05/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/05/2024
Vascular Disease Management
Late-Breaking Trials
Second Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Late-Breaking Trials
First Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Image-Guided Therapy
Philips Enrolls First Patient in U.S. Clinical Trial for Innovative Integrated Single-Device to Treat Peripheral Artery Disease
11/04/2024
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first...
11/04/2024
Vascular Disease Management
Pulmonary Embolism
Akura Medical Secures FDA Approval for US Pivotal Trial in Pulmonary Embolism
11/04/2024
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate...
11/04/2024
Vascular Disease Management
Peripheral Arterial Disease
FDA Grants R3 Vascular IDE Approval for ELITE-BTK Pivotal Trial of its MAGNITUDE® Drug Eluting Next Generation Bioresorbable Scaffold for Below-the-Knee Peripheral Arterial Disease
11/04/2024
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November...
11/04/2024
Vascular Disease Management
Patient Awareness
Baby Boomers Beware: More Americans Than Ever Before Now at Higher Risk for Common Blood Vessel Diseases
10/31/2024
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in...
10/31/2024
Vascular Disease Management
DCB
SIRONA Trial @TCT – First Head-to-Head Comparison of Sirolimus Versus Paclitaxel DCBs in the Treatment of PAD: Sirolimus-Coated Balloons Yield Similar Results to Paclitaxel-Coated Balloons in the Femoropopliteal Artery
10/30/2024
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective,...
10/30/2024
Cath Lab Digest

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement